Tumor response assessment on imaging following immunotherapy

Tumor response assessment on imaging following immunotherapy

In recent years, various systemic immunotherapies have been developed for cancer treatment, such as monoclonal antibodies (mABs) directed against immune checkpoints (immune checkpoint inhibitors, ICIs), oncolytic viruses, cytokines, cancer vaccines, and adoptive cell transfer. While being estimated...

Full description

Bibliographic Details
Main Authors: Antonia M. Berz, Clarisse Dromain, Naïk Vietti-Violi, Sarah Boughdad, Rafael Duran
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
tumor response
immunotherapy
immune checkpoint inhibitor
pseudoprogression
iRECIST
imRECIST
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.982983/full

Similar Items

Similar Items